StockIQpro
NASDAQ:VSTM

Verastem, Inc.

Verastem, Inc.'s revenue grew 209.1% in fiscal 2025 to $30.9M while operating margin rose to −550.3%. The diluted share count rose 94.1%.Summary generated from Verastem, Inc.'s SEC filings. Latest annual report filed Mar 4, 2026.

Revenue (FY25)$30.9M
Revenue growth+209.1%
Revenue, 5-yr CAGR−19.0%
Gross marginn/a
Operating margin−550.3%
Net margin−677.6%
ROICn/a
Return on equity−1480.2%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+94.1%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue23n/a1031
Operating income−61−73−92−115−170
Net income−71−74−87−131−209
Free cash flow−54n/an/a−105n/a

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations